Martin Sadowski is the Zachary Elizabeth M. Fisher Professor of Neurodegeneration Alzheimer's Disease at NYU Grossman School of Medicine, where he is dedicated to studying Alzheimer's disease and other neurodegenerative conditions. His journey in neurology began with a fascination for the effects of neurodegeneration on memory and cognition. He earned his MD and PhD in neuroanatomy from the Medical University of Gdansk, after which he completed his residency in neurology at NYU Medical Center. Sadowski has led multiple clinical trials investigating the efficacy of new Alzheimer’s therapies, including monoclonal antibodies like Leqembi. He is currently the director of the Fisher Center Alzheimer's Clinical Trials Program and CURE AD Lab, where his research focuses on understanding the molecular mechanisms of Alzheimer's and developing new therapeutic solutions. His work has garnered significant awards, including the Markey Career Development Award and the NIH K02 Independent Scientist Award. Sadowski is also involved in teaching and mentoring the next generation of neurologists, bridging the gap between laboratory research and clinical application to improve patient outcomes.
NYU Grossman School of Medicine • New York, NY
Leads a research group focused on Alzheimer's disease and neurodegeneration, exploring therapeutic targets and clinical applications.
Fisher Center Alzheimer's Clinical Trials Program • NYU Grossman School of Medicine
Oversees clinical trials for Alzheimer's therapies, facilitating research and treatment advancements.